Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04466761 · ClinicalTrials.gov registry record · Phase 1
Ascending Glycan Dietary Supplementation in Healthy Adults
A Phase 1 study, sponsored by University of California, Davis.
- Terminated
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT04466761 is a Phase 1 study that was terminated before completion, run by University of California, Davis. The registered enrollment target is 14 participants.
The verdict
NCT04466761, a Phase 1 study, was terminated before completion, sponsored by University of California, Davis.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
The investigators will conduct a parallel-group, placebo-controlled, randomized, double-blind ascending dose Phase I study of dietary supplementation in healthy individuals to evaluate safety and to determine the pharmacologically effective dose (ED).
Interventions
- DIETARY_SUPPLEMENT Monosaccharide Powder
- OTHER Placebo Comparator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-06-23 |
| Est. Completion | 2024-08-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04466761
The ClinicalTrials.gov registry entry for NCT04466761 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Monosaccharide Powder is the first listed.
NCT04466761 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04466761 about?
NCT04466761 is a clinical study titled "Ascending Glycan Dietary Supplementation in Healthy Adults". The investigators will conduct a parallel-group, placebo-controlled, randomized, double-blind ascending dose Phase I study of dietary supplementation in healthy individuals to evaluate safety and to determine the pharmacologically effective dose (ED).
What is the current status of trial NCT04466761?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2022-06-23. Estimated completion is 2024-08-06.
What interventions are being tested in trial NCT04466761?
The interventions under investigation include: Monosaccharide Powder (DIETARY_SUPPLEMENT), Placebo Comparator (OTHER).
Who is sponsoring clinical trial NCT04466761?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.